Molekulargenetisches Labor
Zentrum für Nephrologie und Stoffwechsel
Moldiag Erkrankungen Gene Support Kontakt

Pseudohyperparathyreoidismus

Der Pseudohyperparathyreoidismus ist gekennzeichnet durch Hypercalciämie, Hypophosphatämie bei Hypercalciurie und Hyperphosphaturie wobei das PTH und das PTH-related Protein supprimiert sind.

Gliederung

Erkrankungen der Nebenschilddrüse
Humorale paraneoplastische Hypercalciämie
Hyperparathyreoidismus
Hypoparathyreoidismus
Karzinom der Nebenschilddrüse
Nebenschilddrüsenadenom
Pseudohyperparathyreoidismus
Murk-Jansen metaphyseale Chondrodysplasie
PTH1R
Pseudohypoparathyreoidismus

Referenzen:

1.

Gordon SL et al. (1976) Jansen's metaphyseal dysostosis.

external link
2.

Chen L et al. (2001) A Ser(365)-->Cys mutation of fibroblast growth factor receptor 3 in mouse downregulates Ihh/PTHrP signals and causes severe achondroplasia.

external link
3.

Minagawa M et al. (2002) Association between AAAG repeat polymorphism in the P3 promoter of the human parathyroid hormone (PTH)/PTH-related peptide receptor gene and adult height, urinary pyridinoline excretion, and promoter activity.

external link
4.

Mahon MJ et al. (2002) Na(+)/H(+ ) exchanger regulatory factor 2 directs parathyroid hormone 1 receptor signalling.

external link
5.

Bastepe M et al. (2004) A form of Jansen's metaphyseal chondrodysplasia with limited metabolic and skeletal abnormalities is caused by a novel activating parathyroid hormone (PTH)/PTH-related peptide receptor mutation.

external link
6.

Rozeman LB et al. (2004) Enchondromatosis (Ollier disease, Maffucci syndrome) is not caused by the PTHR1 mutation p.R150C.

external link
7.

Scillitani A et al. (2006) A functional polymorphism in the PTHR1 promoter region is associated with adult height and BMD measured at the femoral neck in a large cohort of young caucasian women.

external link
8.

Wang B et al. (2008) Na/H exchange regulatory factor 1, a novel AKT-associating protein, regulates extracellular signal-regulated kinase signaling through a B-Raf-mediated pathway.

external link
9.

Karaplis AC et al. (1994) Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene.

external link
10.

Hopyan S et al. (2002) A mutant PTH/PTHrP type I receptor in enchondromatosis.

external link
11.

Holthusen W et al. (1975) The skull in metaphyseal chondrodysplasia type Jansen.

external link
12.

None (1969) Metaphyseal dysostosis of Jansen.

external link
13.

de Haas WH et al. (1969) Metaphysial dysostosis. A late follow-up of the first reported case.

external link
14.

Charrow J et al. (1984) The Jansen type of metaphyseal chondrodysplasia: confirmation of dominant inheritance and review of radiographic manifestations in the newborn and adult.

external link
15.

Kruse K et al. (1993) Calcium metabolism in the Jansen type of metaphyseal dysplasia.

external link
16.

Schipani E et al. (1997) Constitutive activation of the cyclic adenosine 3',5'-monophosphate signaling pathway by parathyroid hormone (PTH)/PTH-related peptide receptors mutated at the two loci for Jansen's metaphyseal chondrodysplasia.

external link
17.

None (2002) Some chondrodysplasias with short limbs: molecular perspectives.

external link
18.

Fukumoto S et al. (1996) Absence of mutations in parathyroid hormone (PTH)/PTH-related protein receptor complementary deoxyribonucleic acid in patients with pseudohypoparathyroidism type Ib.

external link
19.

Loshkajian A et al. (1997) Familial Blomstrand chondrodysplasia with advanced skeletal maturation: further delineation.

external link
20.

Jobert AS et al. (1998) Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia.

external link
21.

Zhang P et al. (1998) A homozygous inactivating mutation in the parathyroid hormone/parathyroid hormone-related peptide receptor causing Blomstrand chondrodysplasia.

external link
22.

Hoogendam J et al. (2007) Novel mutations in the parathyroid hormone (PTH)/PTH-related peptide receptor type 1 causing Blomstrand osteochondrodysplasia types I and II.

external link
23.

Duchatelet S et al. (2005) Recessive mutations in PTHR1 cause contrasting skeletal dysplasias in Eiken and Blomstrand syndromes.

external link
24.

Decker E et al. (2008) PTHR1 loss-of-function mutations in familial, nonsyndromic primary failure of tooth eruption.

external link
25.

Lanske B et al. (1996) PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth.

external link
26.

Schipani E et al. (1995) A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia.

external link
27.

Minagawa M et al. (2001) Analysis of the P3 promoter of the human parathyroid hormone (PTH)/PTH-related peptide receptor gene in pseudohypoparathyroidism type 1b.

external link
28.

Schipani E et al. (1996) Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia.

external link
29.

Parfitt AM et al. (1996) Hypercalcemia due to constitutive activity of the parathyroid hormone (PTH)/PTH-related peptide receptor: comparison with primary hyperparathyroidism.

external link
30.

Bettoun JD et al. (1997) Cloning and characterization of the promoter regions of the human parathyroid hormone (PTH)/PTH-related peptide receptor gene: analysis of deoxyribonucleic acid from normal subjects and patients with pseudohypoparathyroidism type 1b.

external link
31.

Schipani E et al. (1999) A novel parathyroid hormone (PTH)/PTH-related peptide receptor mutation in Jansen's metaphyseal chondrodysplasia.

external link
32.

Karperien M et al. (1999) A frame-shift mutation in the type I parathyroid hormone (PTH)/PTH-related peptide receptor causing Blomstrand lethal osteochondrodysplasia.

external link
33.

Manen D et al. (2000) Positive and negative control of the expression of parathyroid hormone (PTH)/PTH-related protein receptor via proximal promoter P3 in human osteoblast-like cells.

external link
34.

OMIM.ORG article

Omim 168468 external link
Update: 14. August 2020
Copyright © 2005-2020 Zentrum für Nephrologie und Stoffwechsel, Dr. Mato Nagel
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Deutschland, Tel.: +49-3576-287922, Fax: +49-3576-287944
Seitenüberblick | Webmail | Haftungsausschluss | Datenschutz